Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$36.3M Sell
126,091
-20,165
-14% -$5.49M 0.05% 162
2023
Q3
$39.3M Buy
146,256
+3,474
+2% +$867K 0.06% 152
2023
Q2
$31.7M Sell
142,782
-360,447
-72% -$83.6M 0.05% 170
2023
Q1
$122M Sell
503,229
-173,029
-26% -$42.5M 0.2% 112
2022
Q4
$178M Sell
676,258
-10,191
-1% -$2.73M 0.31% 90
2022
Q3
$155M Buy
686,449
+60,352
+10% +$14.6M 0.29% 92
2022
Q2
$152M Sell
626,097
-30,938
-5% -$7.58M 0.27% 95
2022
Q1
$159M Buy
657,035
+31,052
+5% +$7.13M 0.24% 101
2021
Q4
$141M Sell
625,983
-38,381
-6% -$8.1M 0.2% 115
2021
Q3
$141M Buy
664,364
+18,805
+3% +$4.33M 0.22% 113
2021
Q2
$157M Sell
645,559
-1,288,563
-67% -$317M 0.24% 106
2021
Q1
$481M Sell
1,934,122
-27,255
-1% -$6.5M 0.8% 31
2020
Q4
$451M Buy
1,961,377
+7,978
+0.4% +$1.84M 0.8% 31
2020
Q3
$496M Sell
1,953,399
-164,769
-8% -$40.8M 0.98% 24
2020
Q2
$500M Sell
2,118,168
-17,948
-0.8% -$4.09M 1.06% 22
2020
Q1
$433M Sell
2,136,116
-129,100
-6% -$28.2M 1.13% 18
2019
Q4
$546M Buy
2,265,216
+203,549
+10% +$44.9M 1.12% 16
2019
Q3
$399M Buy
2,061,667
+210,594
+11% +$40.4M 0.89% 22
2019
Q2
$341M Buy
1,851,073
+151,910
+9% +$27.2M 0.76% 24
2019
Q1
$323M Buy
1,699,163
+1,091
+0.1% +$208K 0.75% 25
2018
Q4
$331M Buy
1,698,072
+7,235
+0.4% +$1.41M 0.87% 26
2018
Q3
$350M Sell
1,690,837
-33,213
-2% -$6.55M 0.76% 30
2018
Q2
$318M Buy
1,724,050
+31,875
+2% +$5.64M 0.72% 30
2018
Q1
$288M Sell
1,692,175
-208,503
-11% -$38.3M 0.67% 27
2017
Q4
$331M Buy
1,900,678
+204,371
+12% +$36.2M 0.74% 22
2017
Q3
$316M Buy
1,696,307
+845,562
+99% +$150M 0.73% 30
2017
Q2
$147M Sell
850,745
-620,028
-42% -$101M 0.34% 84
2017
Q1
$241M Sell
1,470,773
-86,635
-6% -$14.4M 0.57% 40
2016
Q4
$228M Buy
1,557,408
+131,223
+9% +$19.7M 0.55% 44
2016
Q3
$238M Buy
1,426,185
+39,109
+3% +$6.61M 0.57% 43
2016
Q2
$211M Buy
1,387,076
+23,311
+2% +$3.62M 0.51% 50
2016
Q1
$204M Sell
1,363,765
-182,487
-12% -$27.1M 0.49% 47
2015
Q4
$251M Buy
1,546,252
+34,427
+2% +$5.41M 0.57% 36
2015
Q3
$209M Buy
1,511,825
+1,214,026
+408% +$191M 0.47% 41
2015
Q2
$45.7M Sell
297,799
-6,459
-2% -$1.03M 0.09% 211
2015
Q1
$48.6M Buy
304,258
+8,250
+3% +$1.3M 0.1% 215
2014
Q4
$47.2M Buy
296,008
+2,227
+0.8% +$347K 0.1% 216
2014
Q3
$41.3M Buy
293,781
+3,323
+1% +$434K 0.09% 208
2014
Q2
$34.4M Buy
290,458
+558
+0.2% +$64.6K 0.07% 250
2014
Q1
$35.8M Sell
289,900
-11,268
-4% -$1.37M 0.08% 239
2013
Q4
$34.4M Sell
301,168
-317,225
-51% -$36.1M 0.08% 247
2013
Q3
$69.2M Buy
618,393
+53,933
+10% +$5.85M 0.19% 140
2013
Q2
$55.7M Buy
+564,460
New +$58.6M 0.16% 156

Other funds holding AMGN

Putnam Investments's AMGN Position: Q4 2023 in Review

Putnam Investments reduced its Amgen (AMGN) stake by 14% in Q4 2023, selling an estimated $5.49M and leaving 126,091 shares worth $36.3M. The position accounts for 0.05% of the portfolio, ranked #162.

Putnam Investments first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $546M in Q4 2019. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Putnam Investments held 126,091 shares of Amgen worth $36.3M as of Q4 2023.
  • Putnam Investments sold 20,165 Amgen shares in Q4 2023, an estimated $5.49M.
  • Amgen made up 0.05% of Putnam Investments's portfolio in Q4 2023, its #162 holding.
  • Putnam Investments first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
  • Putnam Investments's Amgen position peaked at $546M in Q4 2019.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.